Cargando…

Experimental Murine Models for Colorectal Cancer Research

SIMPLE SUMMARY: In its early stages, colorectal cancer (CRC) is a localized tumor, but when it metastasizes, it has dramatic consequences. Murine models in CRC research are important tools for advancing the knowledge in diagnostic and treatment of this pathology. The present review aims to provide a...

Descripción completa

Detalles Bibliográficos
Autores principales: Neto, Íris, Rocha, João, Gaspar, Maria Manuela, Reis, Catarina P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177088/
https://www.ncbi.nlm.nih.gov/pubmed/37174036
http://dx.doi.org/10.3390/cancers15092570
Descripción
Sumario:SIMPLE SUMMARY: In its early stages, colorectal cancer (CRC) is a localized tumor, but when it metastasizes, it has dramatic consequences. Murine models in CRC research are important tools for advancing the knowledge in diagnostic and treatment of this pathology. The present review aims to provide a variety of murine models in CRC research describing their particular advantages and drawbacks. ABSTRACT: Colorectal cancer (CRC) is the third most prevalent malignancy worldwide and in both sexes. Numerous animal models for CRC have been established to study its biology, namely carcinogen-induced models (CIMs) and genetically engineered mouse models (GEMMs). CIMs are valuable for assessing colitis-related carcinogenesis and studying chemoprevention. On the other hand, CRC GEMMs have proven to be useful for evaluating the tumor microenvironment and systemic immune responses, which have contributed to the discovery of novel therapeutic approaches. Although metastatic disease can be induced by orthotopic injection of CRC cell lines, the resulting models are not representative of the full genetic diversity of the disease due to the limited number of cell lines suitable for this purpose. On the other hand, patient-derived xenografts (PDX) are the most reliable for preclinical drug development due to their ability to retain pathological and molecular characteristics. In this review, the authors discuss the various murine CRC models with a focus on their clinical relevance, benefits, and drawbacks. From all models discussed, murine CRC models will continue to be an important tool in advancing our understanding and treatment of this disease, but additional research is required to find a model that can correctly reflect the pathophysiology of CRC.